> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Bipartisan Brain Cancer Research Bill In
- URL: https://www.fdaweb.com/bipartisan-brain-cancer-research-bill-in/
- Published: 2025-04-10T12:00:00.000Z
- Updated: 2026-09-14T14:57:32.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5158982

Sen. **Richard Blumenthal** (D-CT) and Rep. **Brian Fitzpatrick** (R-PA) have introduced the Bolstering Research and Innovation Now (BRAIN) Act to advance research for brain cancer and improve brain tumor treatment and care. A [statement](https://www.blumenthal.senate.gov/newsroom/press/release/blumenthal-and-fitzpatrick-lead-bipartisan-legislation-to-advance-brain-cancer-research%5Fdevelopment?ref=fdaweb.com) (includes links to the bill text) issued by Blumenthal lists three bipartisan Senate co-sponsors and three bipartisan House co-sponsors.

Blumenthal says the legislation “takes a comprehensive, complementary approach to reduce mortality rates and make meaningful progress against brain tumors.” He says the bill specifically would:

1. direct FDA to issue guidance to ensure brain tumor and other rare and recalcitrant cancer patients have access to clinical trials evaluating treatments for other diseases;
2. increase transparency of federally-funded biobank collections so that researchers are aware of others who possess samples that might be shared to enable important research;
3. provide sufficient resources to the National Cancer Institute’s Glioblastoma Therapeutics Network so that it can realize its promise of vetting treatments and completing innovative early-phase clinical trials;
4. enable team science to advance immunotherapy research (CAR-T) engineered to attack brain cancer cells;
5. directs the Centers for Disease Control to conduct a public education campaign around the importance of clinical trials and biomarker testing in cancer treatment; and
6. augment and expand funding to develop innovative systems of care models for brain tumor survivors.